Drug dealers involved in running County Lines operation across the West Midlands including in Birmingham, Solihull and the ...
Wholesale prices are in the gutter across much of Europe, forcing drug smugglers to try to manipulate the market. OCCRP ...
Although lowering drug costs is one of the few issues uniting almost all Americans, the president has done little to ...
Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trump’s ‘most-favored nation’ pricing plan ...
Opinion
Jacksonville Journal-Courier on MSNOpinion
Commentary: Why Most Favored Nation price controls could leave my patients in pain— Erin Arnold
Commentary: Lowering drug costs is important and an issue we must address as a nation, but the solution is not as simple as that proposed.
In the third entry of Pharmacuetical Executive’s premium webinar series examining the impact of President Trump’s MFN ...
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.
Pharmaceutical Technology on MSN
Trump hits long-term pledge as US prices of weight loss drugs slashed
Eli Lilly and Novo Nordisk have agreed pricing deals for GLP-1RA brands, a pivotal moment in the obesity treatment market.
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded ...
The new legislation means that anyone caught with personal-use amounts of nine illegal drugs — including cocaine, MDMA, ice, ...
News-Medical.Net on MSN
WHO reviews highlight limited long-term data on GLP-1 drug safety
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results